Schroder Investment Management Group
EXAS

Schroder Investment Management Group’s Exact Sciences EXAS Stock Holding History

Schroder Investment Management Group’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,210,865
Closed -$64.6M – 1167
2025
Q3 		$64.6M Buy
1,210,865
+399,665
+49% +$20M 0.05% 241
2025
Q2 		$43.1M Buy
811,200
+53,792
+7% +$2.73M 0.04% 334
2025
Q1 		$33.1M Buy
757,408
+52,628
+7% +$2.67M 0.03% 371
2024
Q4 		$39.6M Buy
704,780
+34,063
+5% +$2.12M 0.04% 358
2024
Q3 		$44.2M Buy
670,717
+306,326
+84% +$17.3M 0.05% 324
2024
Q2 		$15.4M Buy
364,391
+268,409
+280% +$14.8M 0.02% 538
2024
Q1 		$6.63M Sell
95,982
-1,938
-2% -$123K 0.01% 732
2023
Q4 		$7.24M Buy
97,920
+87,445
+835% +$5.73M 0.01% 694
2023
Q3 		$715K Sell
10,475
-767
-7% -$65.1K ﹤0.01% 1053
2023
Q2 		$1.06M Sell
11,242
-913
-8% -$71.2K ﹤0.01% 1046
2023
Q1 		$824K Buy
12,155
+1,102
+10% +$70.8K ﹤0.01% 1079
2022
Q4 		$547K Hold
11,053
– – ﹤0.01% 1132
2022
Q3 		$359K Hold
11,053
– – ﹤0.01% 1184
2022
Q2 		$436K Buy
11,053
+1,407
+15% +$75.2K ﹤0.01% 1189
2022
Q1 		$688K Buy
9,646
+3,163
+49% +$231K ﹤0.01% 1179
2021
Q4 		$505K Buy
6,483
+607
+10% +$53.6K ﹤0.01% 1111
2021
Q3 		$561K Buy
5,876
+428
+8% +$45.2K ﹤0.01% 1191
2021
Q2 		$677K Buy
5,448
+1,229
+29% +$147K ﹤0.01% 1195
2021
Q1 		$556K Buy
4,219
+727
+21% +$99.5K ﹤0.01% 1248
2020
Q4 		$462K Hold
3,492
– – ﹤0.01% 1213
2020
Q3 		$368K Hold
3,492
– – ﹤0.01% 1122
2020
Q2 		$304K Buy
3,492
+532
+18% +$42.5K ﹤0.01% 1051
2020
Q1 		$185K Buy
+2,960
New +$240K ﹤0.01% 1117
2019
Q2 		– Sell
-5,228
Closed -$453K – 1210
2019
Q1 		$453K Sell
5,228
-698
-12% -$59.4K ﹤0.01% 1009
2018
Q4 		$374 Sell
5,926
-674
-10% -$46.3K ﹤0.01% 1029
2018
Q3 		$521K Buy
+6,600
New +$430K ﹤0.01% 1021
2014
Q4 		– Sell
-275,700
Closed -$5.34M – 1383
2014
Q3 		$5.34M Sell
275,700
-420,100
-60% -$7.7M 0.01% 772
2014
Q2 		$11.8M Buy
695,800
+28,800
+4% +$397K 0.01% 598
2014
Q1 		$9.45M Buy
+667,000
New +$9.01M 0.01% 637

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Schroder Investment Management Group's EXAS Position: Q4 2025 in Review

Schroder Investment Management Group sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 1,210,865 shares — an estimated $64.6M sold.

Schroder Investment Management Group first reported a position in EXAS in Q1 2014 and held it in 29 quarters. The position peaked at $64.6M in Q3 2025. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Schroder Investment Management Group reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • Schroder Investment Management Group sold 1,210,865 Exact Sciences shares in Q4 2025, an estimated $64.6M.
  • Schroder Investment Management Group first reported a position in Exact Sciences in Q1 2014 and held it in 29 quarters.
  • Schroder Investment Management Group's Exact Sciences position peaked at $64.6M in Q3 2025.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Schroder Investment Management Group's 13F filing for Q4 2025, filed 13 Feb 2026.